Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Metastatic Colorectal Cancer Patients”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableActive Not RecruitingNCT03451370
What this trial is testing

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Elderly Metastatic Colorectal Cancer Patients
Istituto Oncologico Veneto IRCCS 121
Not applicableLooking for participantsNCT03711110
What this trial is testing

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

Who this might be right for
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)ElderlyAntineoplastic Agents+1 more
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 514
Testing effectiveness (Phase 2)Study completedNCT03142516
What this trial is testing

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

Who this might be right for
Colorectal NeoplasmsColorectal CarcinomaColorectal Cancer Metastatic+1 more
Grupo Espanol Multidisciplinario del Cancer Digestivo 20
Testing effectiveness (Phase 2)Study completedNCT00104689
What this trial is testing

Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
UNICANCER 60
Post-approval studies (Phase 4)Study completedNCT00812864
What this trial is testing

Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)

Who this might be right for
Breast CancerColorectal Cancer
University Hospital, Limoges 20
Not applicableActive Not RecruitingNCT03449914
What this trial is testing

The GOLD Study: G8 in OLDer Patients

Who this might be right for
Elderly Metastatic Colorectal Cancer Patients
Istituto Oncologico Veneto IRCCS 109
Testing effectiveness (Phase 2)UnknownNCT00303745
What this trial is testing

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Study completedNCT03530267
What this trial is testing

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 124
Testing effectiveness (Phase 2)Ended earlyNCT01993472
What this trial is testing

Study of Andrographolides With or Without Capecitabine to Treat Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Gu Yanhong 308
Testing effectiveness (Phase 2)UnknownNCT02904031
What this trial is testing

Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients

Who this might be right for
Elderly Metastatic Colorectal Cancer Patients
Gruppo Oncologico del Nord-Ovest 180
Not applicableStudy completedNCT06704646
What this trial is testing

Predictors of One-Year Mortality After Curative Surgery in Patients Aged 80 Years or Older With Non-Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 310
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Testing effectiveness (Phase 2)UnknownNCT01067053
What this trial is testing

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

Who this might be right for
Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 69
Testing effectiveness (Phase 2)Study completedNCT01417494
What this trial is testing

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 102
Testing effectiveness (Phase 2)Study completedNCT00049335
What this trial is testing

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 29
Testing effectiveness (Phase 2)Ended earlyNCT01718808
What this trial is testing

Cetuximab for Elderly Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer
Swiss Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT00251186
What this trial is testing

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Who this might be right for
Colorectal Cancer
University of Medicine and Dentistry of New Jersey 18
Testing effectiveness (Phase 2)Ended earlyNCT00107315
What this trial is testing

Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06665087
What this trial is testing

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Who this might be right for
Colon CancerRectal Cancer
Fudan University 110
Testing effectiveness (Phase 2)Study completedNCT01024504
What this trial is testing

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 46
Load More Results